⌘K

Login Start Free

Home/Filings/4/0001839882-25-012472

4//SEC Filing

Treco James 4

Accession 0001839882-25-012472

CIK 0001430306other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 5:31 PM ET

Size

4.9 KB

Accession

0001839882-25-012472

Insider Transaction Report

Form 4

Period: 2025-02-05

Tonix Pharmaceuticals Holding Corp.TNXP

Director

Transactions

Other
Common Stock, par value $0.001
2025-02-05$0.30/sh−0.02$0→ 0 total

Footnotes (1)

[F1]Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock.

Documents

1 file

4
treco-form4_022825.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1

filerCIK 0001766070

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 5:31 PM ET
Size: 4.9 KB

View on SEC.gov